The COVID-19 pandemic and China’s health care system: Current impact and long-term prospects

Cover Page

Cite item

Full Text

Abstract

The COVID-19 pandemic is a real crisis for global and national economies and health systems around the world. It has already taken many lives, and many people are still complaining about the consequences of being infected with this virus. The pandemic has demonstrated the weaknesses of national health systems - the unpreparedness for emergencies and their rapid prevention. These problems were expressed in the inability to detect the threat early, overloaded medical facilities, acute shortage of personal protective equipment and personnel. Nevertheless, the success of China in the fight against the virus, expressed in effective containment tactics, as well as in the reduction of COVID-19 incidence in the country, cannot be overlooked. The purpose of this article is to analyze the impact of the COVID-19 pandemic on the PRC health care system and its medical reforms. Since 2012, large-scale reforms have been carried out in China to achieve a “basic healthcare system with Chinese features.” Universal health coverage is extremely important because it helps, in addition to equality, to achieve financial well-being for citizens and economic development for the country. The following results were obtained: despite the abundance of negative consequences for the economy and health of citizens, the pandemic contributed to the successful implementation of information technologies in health care; had a positive impact on the relationship between Chinese doctors and patients (which has been in deep crisis for a long time); became the reason for China’s leadership in the world vaccine market for the first time in history. Thus, we can conclude about the dual impact of COVID-19 on the industry. The pandemic has already led to a number of significant changes, and now another wave of infections is hampering reform goals, including the Healthy China 2030 program, which will affect the health and wellbeing of 1.4 billion Chinese, but making long-term predictions in an ever-changing environment is impossible. As practice has shown, initial success in combating the disease is not enough: plans to recover from one health crisis have been replaced by yet another plan to fight the new wave of COVID-19.

About the authors

Maryana A. Gubina

Saint-Petersburg State University

Author for correspondence.
Email: m.gubina@gmail.com
ORCID iD: 0000-0003-0672-8097

PhD in Economics, Associate Professor, Department of World Economy, Faculty of Economics

7-9 Universitetskaya Embankment, St. Petersburg, 199034, Russian Federation

Daria V. Terenteva

Saint-Petersburg State University

Email: dasha.terentyeva.2000@gmail.com
4th year undergraduate student of the “Economics (with advanced study of Chinese economy and Chinese language)”, Faculty of Economics 7-9 Universitetskaya Embankment, St. Petersburg, 199034, Russian Federation

References

  1. Du, Z., Xu, X., Wu, Y., Wang, L., Cowling, B.J., & Meyers, L.A. (2020). Serial interval of COVID-19 among publicly reported confirmed cases. Emerging infectious diseases, 26(6), 1341. https://doi.org/10.3201%2Feid2606.200357
  2. Gao, B., & Dong, J. (2020). Does the impact of COVID-19 improve the doctor-patient relationship in China? The American Journal of the Medical Sciences, 360(3). https://doi.org/10.1016/j.amjms.2020.05.039
  3. Hu, Y., & Chen, S. (2021). What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective. Journal of Travel Medicine, 28(4). https://doi.org/10.1093/jtm/taab026
  4. Huang, Y. (2020). Xi Jinping Won the Coronavirus Crisis. Foreign Affairs, 13.
  5. Jiang, X., Xie, H., Tang, R., Du, Y., Li, T., Gao, J., & Xie, G. (2021). Characteristics of online health care services from China’s largest online medical platform: cross-sectional survey study. Journal of Medical Internet Research, 23(4), e25817. https://doi.org/10.2196/25817
  6. Leung, K., Wu, J.T., Liu, D., & Leung, G.M. (2020). First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. The Lancet, 395(10233), 1382–1393. https://doi.org/10.1016/S0140-6736(20)30746-7
  7. Li, L., Liu, G., Xu, W., Zhang, Y., & He, M. (2020). Effects of internet hospital consultations on psychological burdens and disease knowledge during the early outbreak of COVID-19 in China: Cross-sectional survey study. Journal of Medical Internet Research, 22(8), e19551. https://doi.org/10.2196/19551
  8. Liu, Y., Eggo, R.M., & Kucharski, A.J. (2020). Secondary attack rate and superspreading events for SARS-CoV-2. The Lancet, 395(10227), e47. https://doi.org/10.1016/S0140-6736(20)30462-1
  9. Milcent, C. (2016). Evolution of the health system: Inefficiency, violence, and digital healthcare. China Perspectives, 4, 39–50. https://doi.org/10.4000/chinaperspectives.7112
  10. Milcent, C. (2018). Healthcare reform in China: From violence to digital healthcare. Springer. https://doi.org/10.1007/978-3-319-69736-9
  11. Perkhov, V.I., & Pesennikova, E.V. (2020). Variety of forms of reaction of health care systems of particular countries to the predicted COVID-19 pandemic. Medicine and Health Care Organization, 5(3), 4–12.
  12. Reshetnikova, M.S. (2020). China’s AI experience: Industrial digitalization. RUDN Journal of Economics, 28(3), 536–546. (In Russ.) http://dx.doi.org/10.22363/2313-2329-2020-283-536-546
  13. Sang, T., Zhou, H., Li, M., Li, W., Shi, H., Chen, H., & Zhou, H. (2020). Investigation of the differences between the medical personnel’s and general population’s view on the doctorpatient relationship in China by a cross-sectional survey. Globalization and health, 16(1), 1–12. https://doi.org/10.1186/s12992-020-00625-9
  14. Wu, J.T., Leung, K., & Leung, G.M. (2020). Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet, 395(10225), 689–697. https://doi.org/10.1016/S01406736(20)30260-9
  15. Wu, J.T., Leung, K., Bushman, M., Kishore, N., Niehus, R., de Salazar, P. M ., & Leung, G.M. (2020). Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nature medicine, 26(4), 506–510. https://doi.org/10.1038/s41591-020-0822-7
  16. Xu, X. et al. (2021). Assessment of internet hospitals in China during the COVID-19 pandemic: National cross-sectional data analysis study. Journal of medical Internet research, 23(1). https://doi.org/10.2196/21825
  17. Zhang, J., Yang, H., Yang, M., & Tan, H. (2022). The role of vaccines in COVID-19 control strategies in Singapore and China. Health Policy and Technology, 100620. https://doi.org/10.1016/j.hlpt.2022.100620
  18. Zhou, M., Zhao, L., Campy, K.S., & Wang, S. (2017). Changing of anihC׳s health policy and Doctor–Patient relationship: 1949–2016. Health policy and technology, 6, 358–367.
  19. Zhou, Y., Chen, S., Liao, Y., Wu, Q., Ma, Y., Wang, D., Wang, X., Li, M., Wang, Y., Wang, Y., Liu, Y., Liu, T. and Yang, WFZ. (2021). General Perception of Doctor–Patient Relationship From Patients During the COVID-19 Pandemic in China: A Cross-Sectional Study. Front. Public Health, 9, 646486. https://10.3389/fpubh.2021.646486
  20. Zhou, Y., Ma, Y., Yang, W.F.Z., Wu, Q., Wang, Q., Wang, D., & Wu, X. (2021). Doctor-patient relationship improved during COVID-19 pandemic, but weakness remains. BMC family practice, 22(1). https://doi.org/10.1186/s12875-021-01600-y
  21. Zhu, F.C., Li, Y.H., Guan, X.H., Hou, L.H., Wang, W.J., Li, J.X., & Chen, W. (2020). Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. The Lancet, 395(10240). https://doi.org/10.1016/s0140-6736(20)31208-3

Copyright (c) 2022 Gubina M.A., Terenteva D.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies